Articles Tagged: RAD51D
December 19, 2023
The Path to Clinical Relevance: What a Study on RAD51C Reveals about Resolving VUS
Marcy Richardson, PhD discusses variant interpretation, VUS, and recategorizing missense genes with an example from Hu et al’s recent publication on RAD51C.
Genetic Testing
Genetic Testing Accuracy
PALB2
RAD51D
Variant of Unknown Significance
VUS
April 14, 2017
Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer
Mayo Clinic and Dr. Fergus Couch collaborate with Ambry Genetics in the largest genetic study to date of women with breast cancer.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
HBOC
Mayo Clinic
NCCN
PALB2
RAD51D
December 14, 2016
Dr. Fergus Couch Talks with Ambry about Recent Study Findings
Mayo Clinic Researcher Dr. Fergus Couch talks with Ambry about recent findings from the largest hereditary breast cancer patient study to date.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
Mayo Clinic
RAD51D